Idiopathic Pulmonary Fibrosis
Full Form of IPF
What is IPF?
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and irreversible interstitial lung disease characterized by scarring (fibrosis) of the lung tissue. The term 'idiopathic' means the cause is unknown, though risk factors include smoking, genetic predisposition, and environmental exposures. In India, IPF is increasingly recognized as a significant cause of respiratory morbidity, with diagnosis typically occurring in middle-aged and elderly adults. The disease leads to a decline in lung function, causing symptoms such as persistent dry cough, shortness of breath, fatigue, and clubbing of fingers. Diagnosis is confirmed through high-resolution computed tomography (HRCT) and, in some cases, lung biopsy. IPF is managed with antifibrotic medications like pirfenidone and nintedanib, along with oxygen therapy and pulmonary rehabilitation. The prognosis is poor, with a median survival of 3–5 years from diagnosis. For medical students and healthcare professionals in India, understanding IPF is essential for pulmonary medicine exams like NEET PG and USMLE. Awareness and early referral to specialized centers are critical, as lung transplantation remains the only curative option.
IPF का फुल फॉर्म
अज्ञातहेतुक फुफ्फुसीय फाइब्रोसिस
Example
The patient, a 65-year-old former smoker, presented with progressive dyspnea and a HRCT pattern consistent with usual interstitial pneumonia, leading to a diagnosis of IPF.